Development code · Small Molecule
ITI-007
ITI-007 is a development code for Lumateperone (ITI-007), developed by Intra-Cellular Therapies, Inc..
- Status
- Approved for Schizophrenia
- Mechanism
- 5-HT2A Antagonist
- Developer
- Intra-Cellular Therapies, Inc.
Programs
- Lumateperone (ITI-007) for SchizophreniaApprovedApproved
- Lumateperone (ITI-007) for Major depressive disorderApprovedApproved
- Lumateperone (ITI-007) for Bipolar depressionApprovedApproved
- Lumateperone (ITI-007) for Bipolar disorderPhase 3Recruiting
- Lumateperone (ITI-007) for Autism spectrum disorderPhase 3Recruiting
Also known as
- ITI-722
- Caplyta
- lumateperone
- 313368-91-1